Concanavalin A-activated suppressor cell activity in gastric cancer patients.

Tetsuya Toge(Hiroshima University), Takao Hattori(Hiroshima University), Minoru Niimoto(Hiroshima University), Kohzo Nakanishi(Hiroshima University), Etsuro Yanagawa(Hiroshima University), Yoshitaka Yamada(Hiroshima University)
PubMed
December 1, 1980
Cited by 13

Related Papers

Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
The role of Fas ligand and transforming growth factor β in tumor progression
|Cancer|2004|135
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111
Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy
|Cancer|2004|110